1. Home
  2. AAPG vs VIRT Comparison

AAPG vs VIRT Comparison

Compare AAPG & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • VIRT
  • Stock Information
  • Founded
  • AAPG 2009
  • VIRT 2008
  • Country
  • AAPG China
  • VIRT United States
  • Employees
  • AAPG N/A
  • VIRT N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • VIRT Investment Bankers/Brokers/Service
  • Sector
  • AAPG Health Care
  • VIRT Finance
  • Exchange
  • AAPG Nasdaq
  • VIRT Nasdaq
  • Market Cap
  • AAPG 3.6B
  • VIRT 2.8B
  • IPO Year
  • AAPG 2025
  • VIRT 2015
  • Fundamental
  • Price
  • AAPG $31.73
  • VIRT $35.64
  • Analyst Decision
  • AAPG Buy
  • VIRT Hold
  • Analyst Count
  • AAPG 2
  • VIRT 7
  • Target Price
  • AAPG $48.00
  • VIRT $41.43
  • AVG Volume (30 Days)
  • AAPG 8.4K
  • VIRT 1.0M
  • Earning Date
  • AAPG 11-19-2025
  • VIRT 10-29-2025
  • Dividend Yield
  • AAPG N/A
  • VIRT 2.69%
  • EPS Growth
  • AAPG N/A
  • VIRT 132.69
  • EPS
  • AAPG N/A
  • VIRT 4.62
  • Revenue
  • AAPG $54,524,554.00
  • VIRT $2,694,104,000.00
  • Revenue This Year
  • AAPG N/A
  • VIRT N/A
  • Revenue Next Year
  • AAPG $368.64
  • VIRT N/A
  • P/E Ratio
  • AAPG N/A
  • VIRT $7.72
  • Revenue Growth
  • AAPG N/A
  • VIRT 41.05
  • 52 Week Low
  • AAPG $16.50
  • VIRT $31.89
  • 52 Week High
  • AAPG $48.45
  • VIRT $45.77
  • Technical
  • Relative Strength Index (RSI)
  • AAPG 32.13
  • VIRT 60.38
  • Support Level
  • AAPG $32.68
  • VIRT $34.28
  • Resistance Level
  • AAPG $34.31
  • VIRT $35.43
  • Average True Range (ATR)
  • AAPG 0.84
  • VIRT 0.89
  • MACD
  • AAPG -0.08
  • VIRT 0.31
  • Stochastic Oscillator
  • AAPG 8.71
  • VIRT 96.26

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About VIRT Virtu Financial Inc.

Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.

Share on Social Networks: